Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study.

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

The FDA’s approval was based on a study of 11,400 people ages 12 and older that compared the new low-dose vaccine with Moderna’s existing vaccine.

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

NASHVILLE, Tenn. – The U.S. Army will field its first Future Long-Range Assault Aircraft, commonly known as FLRAA, to the Screaming Eagles of the 101st Airborne Division at Fort Campbell ...

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how sponsors can align with FDA expectations and implement more precise ...

Extended anticoagulation with reduced-dose apixaban was noninferior to full-dose apixaban for the prevention of recurrent venous thromboembolism in patients with active cancer.

Learn more about fluoxetine dosage, including available strengths, forms, and how it’s taken.

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain manageme ...

PK data analysis in dose-escalation phase indicated exposures of QRL-201 met or exceeded the targeted therapeutic range prompting advancement to the DRF phase ANQUR protocol amended to include ...

PK data analysis in dose-escalation phase indicated exposures of QRL-201 met or exceeded the targeted therapeutic range prompting advancement to the DRF phase ANQUR protocol amended to include ...